>





USP-grade sterile water for in-vitro dilution use, preserved with 0.9% benzyl alcohol. Manufactured by Pfizer; supplied as-is.
Bacteriostatic Water for Injection is a sterile, non-pyrogenic preparation of water for injection containing 0.9% (w/v) benzyl alcohol as a bacteriostatic preservative. The benzyl alcohol inhibits microbial growth, allowing multi-use sampling from a single vial within the labeled in-use window.
Lumera supplies the Pfizer-manufactured product unchanged; the original USP labeling and Pfizer lot number ship with each vial. Stored and shipped at 2–25 °C.
In-vitro dilution and reconstitution of lyophilized peptide reference standards. The benzyl alcohol preservative is compatible with most peptide chemistry; verify compatibility for any specific reference standard.
Sold for laboratory research only. This material is not a drug, food, or cosmetic and is not intended for diagnostic, therapeutic, or recreational use.
| Parameter | Value |
|---|---|
| Sequence | Sterile-filtered water containing 0.9% (w/v) benzyl alcohol as a bacteriostatic agent |
| Molecular formula | H₂O + C₇H₈O (0.9%) |
| Molecular weight | Mixed (18.02 / 108.14 g/mol) |
| CAS number | 7732-18-5 / 100-51-6 |
| Length | Solvent (not a peptide) |
| Test | Specification |
|---|---|
| HPLC purity | ≥ 99.0% (lot Per Pfizer lot: USP Pharmaceutical grade (Pfizer)) |
| Mass confirmation | ESI-MS within 0.5 Da |
| Net peptide content | ≥ 80% by AAA |
| Endotoxin | < 0.5 EU/mg (LAL) |
| Bioburden | < 10 CFU/g |
| Residual TFA | < 1.0% |
Manufactured 04 Mar 2026 · Released 11 Mar 2026 · Tested by Lumera QC, Kelowna BC. Retain samples held under storage spec for five years from release date.
| Method | Result |
|---|---|
| RP-HPLC at 220 nm | USP Pharmaceutical grade (Pfizer) main peak |
| ESI-MS (positive) | N/A — solvent |
| Amino acid analysis | 82.1% net peptide |
| LAL endotoxin | < 0.05 EU/mg |
| Karl Fischer (water) | 2.8% w/w |
Allow vial to reach room temperature before opening (≥ 20 minutes). Reconstitute with 1.0–2.5 mL of sterile bacteriostatic water (0.9% benzyl alcohol). Inject solvent slowly down the inner wall of the vial; do not direct stream onto the lyophilized cake.
Swirl gently for 30 seconds. Do not vortex. Allow to dissolve for 5 minutes; clarity should be complete with no visible particulates.
Reconstituted solution is stable for 28 days at 2–8 °C in original vial. For longer storage, aliquot into low-binding tubes and hold at −80 °C; avoid repeated freeze-thaw cycles. Discard if turbidity, color change, or particulate matter is observed.
USP General Chapter <1191>. Stability considerations in dispensing practice. United States Pharmacopeia.
Wilson JT et al. Toxicity of preservatives in injectable formulations. J Pediatr. 1986;109(2):394–396.
Pfizer Bacteriostatic Water for Injection prescribing information. Pfizer Inc.
Bacteriostatic Water reference standard, ≥99% (HPLC), Lumera Labs Inc., Cat. No. LUM-BAC-30, Lot 26-A031.